Breast Cancer: Genetic Testing Reduces Chemotherapy in Patients

In this video from MDLinx, Dr. Martine Piccart, PhD & Head of the Medicine Department at the Jules Bordet Institute and Co-Founder of the Breast International Group, talks about a breakthrough study that focuses on how using MammaPrint genetic testing can reduce the use of chemotherapy over-treatment in breast cancer patients.

Learn more about breast cancer: http://bit.ly/learnBreastCancer

Breast Cancer News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.